13F Pro

SEC Form 4 reporting owner

Inrig Jula

Inrig Jula has filed 22 Form 4 transactions reported between December 24, 2025 and September 15, 2026, as EVP, Head of R&D & CMO, CHIEF MEDICAL OFFICER of Travere Therapeutics, Inc..

Name as filed: Inrig Jula

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$3.6M
13 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 15, 2026
transaction date

Roles and reported holdings

  • TVTXTravere Therapeutics, Inc.
    Dec 24, 2025 – Sep 15, 2026

    EVP, Head of R&D & CMO, CHIEF MEDICAL OFFICER

    Held directly100,491 sh as of Sep 15, 2026 · Form 4

    24 months: $3.6M sold

Transaction history

All 22 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 15, 2026TVTXEVP, Head of R&D & CMOOpen-market saleCode S · directAlso reported by Cline Christopher R.400$26K@ $65.31Form 4
Sep 15, 2026TVTXEVP, Head of R&D & CMOOpen-market saleCode S · direct1,600$102K@ $63.69Form 4
Sep 15, 2026TVTXEVP, Head of R&D & CMOOpen-market saleCode S · direct17,284$1.1M@ $62.62Form 4
Sep 15, 2026TVTXEVP, Head of R&D & CMOOpen-market saleCode S · direct25,390$1.6M@ $62.02Form 4
Sep 15, 2026TVTXEVP, Head of R&D & CMOOption exerciseCode M · direct32,395$289K@ $8.93Form 4
Jun 22, 2026TVTXCHIEF MEDICAL OFFICERGiftCode G · direct468—Form 4
May 6, 2026TVTXCHIEF MEDICAL OFFICEROpen-market saleCode S · direct311$14K@ $43.95Form 4
May 5, 2026TVTXCHIEF MEDICAL OFFICEROpen-market saleCode S · directAlso reported by REED ELIZABETH E, Heerma Peter2,174$101K@ $46.65Form 4
May 4, 2026TVTXCHIEF MEDICAL OFFICERGrant or awardCode A · direct8,500—Form 4
May 4, 2026TVTXCHIEF MEDICAL OFFICEROption exerciseCode M · direct4,250—Form 4
May 4, 2026TVTXCHIEF MEDICAL OFFICEROption exerciseCode M · direct20,000$448K@ $22.40Form 4
Apr 15, 2026TVTXCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,018$43K@ $42.61Form 4
Apr 14, 2026TVTXCHIEF MEDICAL OFFICEROpen-market saleCode S · directAlso reported by Heerma Peter, REED ELIZABETH E7,215$303K@ $41.93Form 4
Apr 13, 2026TVTXCHIEF MEDICAL OFFICERGrant or awardCode A · direct14,000—Form 4
Feb 4, 2026TVTXCHIEF MEDICAL OFFICEROpen-market saleCode S · direct232$8K@ $32.85Form 4
Feb 4, 2026TVTXCHIEF MEDICAL OFFICEROpen-market saleCode S · direct1,547$50K@ $32.11Form 4
Feb 3, 2026TVTXCHIEF MEDICAL OFFICEROpen-market saleCode S · direct6,956$223K@ $32.12Form 4
Jan 31, 2026TVTXCHIEF MEDICAL OFFICERGrant or awardCode A · direct75,000—Form 4
Jan 31, 2026TVTXCHIEF MEDICAL OFFICERGrant or awardCode A · direct28,130—Form 4
Jan 6, 2026TVTXCHIEF MEDICAL OFFICEROpen-market saleCode S · direct445$17K@ $37.75Form 4
Jan 5, 2026TVTXCHIEF MEDICAL OFFICEROpen-market saleCode S · direct2,031$82K@ $40.18Form 4
Dec 24, 2025TVTXCHIEF MEDICAL OFFICEROption exerciseCode M · direct15,000$134K@ $8.93Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.